Important notification
23.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that on 9 December […]
Press release
16.12.2022 To the attention of interested persons EMA recommends withdrawal of pholcodine medicines from EU market download document …
Important notification
13.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that Order no. 3539 […]
Important notification
12.12.2022 To the attention of manufacturers of medical devices, in vitro diagnostic medical devices and all stakeholders Please be informed […]
Press release
06.12.2022 To the attention of interested persons ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary […]
Press release
06.12.2022 To the attention of interested persons ETF statement on the use of the EMA approved bivalent original/Omicron BA.4-5 mRNA […]
Important notification
06.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders We hereby inform you that on 1 […]
Important notification
06.12.2022 To the attention of in vitro diagnostics laboratories in Romania and all stakeholders Please be advised that on 30 […]
Press release
02.12.2022 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November – 1 […]
Press release
02.12.2022 To the attention of interested persons EMA recommends withdrawal of pholcodine medicines from EU market download document …